&lt;Ciba-Giegy Corp>'s Ciba-Giegy Pharmaceuticals division said it had an agreement with&lt;Gipharmex S.P.A.> (Giuliani Group), of Milan, Italy, todevelop and eventually market in the U.S. a new gallstonedissolving drug.    The company said the drug, ursodeoxycholic acid, is anaturally occurring bile acid and has been approved formarketing in most European countries and in Japan.    The division said it holds a patent on the use of the drugto dissolve gallstones. Reuter&#3;